Delivery Order SPE2DB20D3101-SPE2DB22FJ0K8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XYLOCAINE-MPF 1% VIAL 5ML, a local anesthetic medication. The contract is a Delivery Order with a Firm Fixed Price of $1,386.88 and an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,612.83 firm fixed-price contract is for the delivery of Xylocaine-MPF 1% vial, 2 mL, a local anesthetic medication. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999.00, providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a local anesthetic medication. The $3,635.91 Firm Fixed Price contract is a Delivery Order that has an ultimate completion date of April 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,946.55 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 1%-EPI 1:200,000 10ML, a local anesthetic medication. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with ID SPE2DX15D1104|SPE2DX24F3FH9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,037.22 firm fixed-price delivery order is for the pharmaceutical product XYLOCAINE-MPF 2% VIAL 5ML, with an ultimate completion date of October 27, 2023. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award, valued at $1,462.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xylocaine 1%-Epi 1:100,000 50ml, a local anesthetic medication. The contract, which has a completion date of December 4, 2023, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Xylocaine 2%-Epi 1:200,000 10ML, a pharmaceutical product. The award has a ceiling value of $8,271.66 and was issued as a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $7,148.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, with a ceiling value of $2,008.60 and a period of performance through June 11, 2025. The contract is designated as a Firm Fixed Price contract and is not set aside for any specific business category. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.11 firm fixed-price delivery order is for the supply of XYLOCAINE-MPF 2% 40 MG/2 ML VL 2ML, a pharmaceutical product, with a period of performance ending on October 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FJ0K8Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,370.88 Firm Fixed Price Delivery Order is for the supply of Xylocaine-MPF 2% Ampul 10ML, a local anesthetic medication. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen, as a for-profit organization, is well-positioned to meet the DLA's requirements for essential medical commodities, leveraging its extensive supply chain and pharmaceutical distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/8/22 |